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Background The Hand Eczema Severity Index (HECSI) is used to measure the sever-
ity of hand eczema. It is unclear what HECSI scores mean and what is the mini-
mally important change (MIC). Furthermore, its responsiveness has not been
studied.
Objectives To study the responsiveness and interpretability of the HECSI.
Methods This was a prospective study covering two time points: baseline and after
4–12 weeks. Responsiveness was assessed using a criterion approach, with at least
one-step improvement on the ‘Photographic guide for severity of hand eczema’
as the anchor for important improvement. Interpretability of single scores was
determined by defining severity bands based on agreement with the anchor. For
change scores, the smallest detectable change (SDC) was calculated in patients
indicating no change and the MIC was obtained in patients indicating that they
had changed using three methods: mean cutoff, receiver operating characteristic
(ROC) curve and 95% limit.
Results In total, 294 patients participated (160 male, mean age 449 years). HECSI
scores improved or deteriorated in parallel with the anchor. The area under the
ROC curve was 086 (95% confidence interval 081–091). The final severity
band for single scores had a j-coefficient of agreement of 0694: clear, 0; almost
clear, 1–16; moderate, 17–37; severe, 38–116; very severe, ≥ 117. The SDC in
93 unchanged patients was 403 points. The obtained MIC values were all smaller
than the SDC.
Conclusions The HECSI has good responsiveness. This study gives meaning to
HECSI scores, which can be applied to clinical decision making and the design of
clinical trials. We recommend that an improvement of 41 points on the HECSI is
regarded as the minimally measurable true change.
What’s already known about this topic?
• The Hand Eczema Severity Index (HECSI) is one of the most widely used measure-
ment instruments to measure the severity of hand eczema.
• The HECSI has good reliability, but its responsiveness and interpretability have not
been studied.
What does this study add?
• This study shows good responsiveness of the HECSI.
• A severity grading for single scores is proposed.
• The smallest detectable change and minimally important change for improvement
are determined.
© 2019 The Authors. British Journal of Dermatology
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What are the clinical implications of this work?
• The obtained values help to interpret HECSI scores in daily practice and clinical
studies, and may facilitate researchers in the calculation of sample sizes for clinical
trials.
Multiple scoring systems exist for determining and monitoring
the severity of hand eczema, but proper validation of most
measurement properties is still lacking for many instruments.1
The Hand Eczema Severity Index (HECSI) is one of the most
widely used measurement instruments for hand eczema sever-
ity and its reliability has been studied by its developers.2
However, the responsiveness (or sensitivity to change) and
interpretability of the HECSI are not known.3 A study from
2009 presented cutoff values for mild (0–11 points), moder-
ate (12–27 points) and severe (≥ 28 points) disease, although
no reference was given.4 These values most likely came from
practical experience, not from a formally conducted inter-
pretability study. Knowledge of whether an instrument can
identify changes over time and an understanding of what sin-
gle scores and change scores mean are vital to the proper use
of such an instrument, both in clinical studies and in daily
practice.5 Therefore, in this study, we aimed to determine the
responsiveness and interpretability of the HECSI.
Patients and methods
Study population and design
This prospective study was performed at the dermatology
department of the University Medical Center Groningen, a ter-
tiary referral centre for hand eczema. Adult patients (age ≥ 18
years) were included if they had hand eczema of at least 1-
week duration, as diagnosed by a dermatologist according to
current guidelines.6,7 Patients were scored with the HECSI and
an anchor for hand eczema severity (a ‘photographic guide
for assessing severity of chronic hand dermatitis’)8 at the out-
patient clinic at two time points: at baseline (T0) and after 4–
12 weeks (T1). Between T0 and T1, patients were allowed to
use any form of treatment. Recruitment was done consecu-
tively between March 2017 and December 2018. The design
of this study was in accordance with guidelines by the COS-
MIN group.5,9 The institutional review board of the University
Medical Center Groningen confirmed that this study did not
fall under the scope of the Medical Research Involving Human
Subjects Act (reference: METc 2014/391).
Studied instrument
The HECSI is a physician-rated instrument covering six signs:
erythema, infiltration/papulation, vesicles, fissures, scaling and
oedema; and five anatomical locations: fingertips, fingers
(except tips), palm of hands, back of hands and wrists. Each
sign is scored on each location with a score of 0–3, with 3
representing the most severe expression of the sign. For each
location, the extent of total eczema involvement is scored 0–4
(0, 0%; 1, 1–25%; 2, 26–50%; 3, 51–75% and 4, 76–100%).
The total sign score is multiplied by the extent score to obtain
a total score, ranging from 0 to 360 points. The reliability of
the HECSI was found to be good to excellent.2
Anchor (external criterion)
The ‘photographic guide for assessing severity of chronic hand
dermatitis’ (or ‘Photoguide’) was used as the anchor to deter-
mine the severity of hand eczema and to define which patients
were changed or unchanged at T1. It covers a five-point scale
(clear, almost clear, moderate, severe, very severe), with photo-
graphic images depicting increasing severity and extent of hand
eczema. It is a global assessment that incorporates a combination
of clinical symptoms and extent. Its reliability was deemed ade-
quate in a previous study.8 In the current study, the Photoguide
was scored by trained healthcare personnel.
Responsiveness of the Hand Eczema Severity Index
To determine the responsiveness of the HECSI we chose a crite-
rion approach, using the Photoguide as the anchor for change in
hand eczema severity. We a priori hypothesized that change
scores of the HECSI would correlate strongly (Spearman’s rho
> 07) with changes on the anchor (Photoguide) and that mean
change scores of the HECSI would increase or decrease in paral-
lel with each step of improvement or deterioration on the Pho-
toguide. Furthermore, we constructed a receiver operating
characteristic (ROC) curve and assessed the area under the curve
(AUC) to determine the discriminate ability of HECSI change
scores. A dichotomized variable was computed including
improved vs. unchanged patients on the Photoguide. Improve-
ment was defined as at least one-step improvement. Patients
whose condition deteriorated were not used in this analysis. We
hypothesized that the AUC of the ROC curve would be > 07. If
our a priori hypotheses were confirmed, we would consider the
responsiveness of the HECSI to be good.5
Interpretability of the Hand Eczema Severity Index
We studied the interpretability of the HECSI for use in single
scores (e.g. ‘what does a HECSI score of . . . mean?’) and in
© 2019 The Authors. British Journal of Dermatology
published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.
British Journal of Dermatology (2019)
2 Responsiveness and interpretability of the HECSI, J.A.F. Oosterhaven et al.
change scores (e.g. ‘what is an important difference in HECSI
scores?’).
Single scores
We used an anchor-based method to define severity strata (or
‘bands’) for the HECSI with scores obtained at T0, using the
Photoguide as the severity anchor. Several numerical cutoffs of
the HECSI score were tested against the severity categories of the
Photoguide using a weighted kappa coefficient of agreement to
determine the highest level of agreement between these.
Numerical cutoff points were considered based on HECSI scores
that corresponded to a one-step increase in mean, median and/
or mode on the Photoguide. Sensitivity analyses consisted of
tests for differences in sex and age distribution between patients
for whom severity could be predicted based on the band with
the highest j-value and patients for whom scores disagreed with
the predicted severity according to that band.10–12
Change scores
The smallest detectable change (SDC) is defined as ‘the small-
est change in score that can be detected by the instrument,
beyond measurement error’.5 The SDC for the HECSI was
determined in patients indicating no change at T1, as identi-
fied using the Photoguide. For this, the standard error of mea-
surement (SEMagreement) was obtained using the square root of
the within-person total variance of an ANOVA analysis. The SDC
was then calculated using the formula: SDC = 196 9 ffiffiffi2p 9
SEMagreement.
13 This was done for the whole HECSI and also
for HECSI scores within the severity bands that were deter-
mined using the Photoguide in the single-score analysis.
The minimally important change (MIC) is defined as ‘the
smallest change in the construct to be measured which is per-
ceived as important’ (by patients and/or clinicians).5 The MIC
for the HECSI score was determined in patients indicating that
they had changed at T1, as identified using the Photoguide. Raw
change scores were calculated for the HECSI and Photoguide by
subtracting the score at T0 from the score at T1. Also, the percent-
age change compared with baseline was calculated using the for-
mula: [(HECSI T0 – HECSI T1) / HECSI T0] 9 100. Thus,
negative scores and percentages correspond to a deterioration,
and positive scores and percentages to an improvement of the
hand eczema. We determined a change of one step in severity on
the Photoguide as the cutoff for an important improvement.
Three MIC values were determined for both raw change scores
and percentage change compared with baseline, as follows:14,15
(i) The MIC based on the mean change in HECSI value or per-
centage that corresponds with a one-step severity change on the
Photoguide; (ii) the MIC of the ROC cutoff point, indicating the
point closest to the upper left corner, where the sum of percent-
ages of correctly classified patients is highest; (iii) the MIC based
on the 95% upper-limit cutoff point of the patients indicating no
change or no important change, which corresponds to meanchange
+ 1645 9 SDchange of this group (or strictly to the meandifference
and SDdifference as this concerns patients indicating no change).
Values for the MIC of the raw HECSI change score were
graphically presented using the visualized anchor-based MIC
distribution method.15 We determined the MIC only for
patients indicating that they had improved. The MIC for dete-
rioration was not feasible to assess, because too few patients
(n < 50) indicated that they had deteriorated compared with
baseline to draw sound conclusions about this.
Floor and ceiling effects
It was determined what proportion of patients achieved the
highest and lowest possible scores on the HECSI. Floor and
ceiling effects were considered to be present if the lowest or
highest HECSI score was achieved by > 15% of patients.16
Data analysis
No sample-size calculation was performed. A general recom-
mendation for interpretability studies is to use a minimum of
50 participants, but preferably at least 100, with a minimum
of 50 in the smallest subgroup to calculate the MIC using the
ROC method.5 This study meets these recommendations.
Spearman’s rho was used to calculate correlations. The v2-test
and Student’s t-test were used to calculate differences between
groups. There were no missing values for the analysed
patients. Analyses were performed with IBM SPSS Statistics for
Windows, version 230 (IBM, Armonk, NY, U.S.A.) and
GraphPad Prism version 702 for Windows (GraphPad Soft-
ware, La Jolla, CA, U.S.A.).
Subgroup analyses
The MIC has been found to vary depending on the baseline
score.17 Therefore, we performed a sensitivity analysis on the
MIC, calculating it also for subgroups (low or high) based on
the median of the baseline HECSI scores.
Results
At baseline, 294 patients were included; their basic character-
istics are presented in Table 1. At T1, 215 patients were avail-
able for assessment. In the group of 79 patients who dropped
out there were significantly more women (35% vs. 20%; v2 =
843, P < 001) and they were significantly younger (mean
418 vs. 460 years; P < 005).
Responsiveness
There was a strong, significant correlation between the change
on the Photoguide and the change on the HECSI: Spearman’s
rho = 075 (P < 0001), which was not significantly affected
by age or sex. Table 2 shows the mean HECSI scores improv-
ing or deteriorating in parallel with the anchor. The AUC
under the ROC curve was 086 (95% confidence interval
081–091) (Fig. 1). These results meet our hypotheses
defined a priori; the HECSI showed good responsiveness.
© 2019 The Authors. British Journal of Dermatology
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Interpretability
Single scores
There was a strong, significant correlation between the Pho-
toguide and the HECSI: Spearman’s rho = 084 (P <
0001), which was not significantly affected by age or sex.
The distribution of HECSI scores stratified by Photoguide
categories is shown in Figure 2. In total, 36 bands for
severity were tested. Details of the testing of single scores
are presented in Tables S1 and S2 (see Supporting Informa-
tion). The band with the highest j-coefficient of agreement
(j = 0694) was chosen as the final severity band: clear, 0;
almost clear, 1–16; moderate, 17–37; severe, 38–116; very
severe, ≥ 117.
Overview of Hand Eczema Severity Index scores falling
outside the proposed banding
One patient (03%) had a Photoguide score > 1 point outside
that predicted by the final HECSI severity band. There were 57
patients (194%) patients with an actual Photoguide score 1
point lower than the final HECSI severity band predicted.
There were 33 patients (112%) with an actual Photoguide
score 1 point higher than the final HECSI severity band pre-
dicted. There were no sex or age distribution differences
Table 1 Basic characteristics of the study population. There were no significant differences between male and female participants
Male (n = 160) Female (n = 134) Total (n = 294)
Age (years)
Mean  SD 450  145 448  175 449  159
Range 18–74 18–83 18–83
HECSI
Mean  SD 486  411 409  355 451  388
Median (IQR) 360 (160–665) 295 (140–553) 335 (150–620)
Range 3–192 2–144 2–192
Photoguide severity
(physician), n (%)
Clear 0 0 0
Almost clear 37 (231) 40 (299) 77 (262)
Moderate 63 (394) 51 (381) 114 (388)
Severe 44 (275) 37 (276) 81 (276)
Very severe 16 (100) 6 (45) 22 (75)
HECSI, Hand Eczema Severity Index; IQR, interquartile range.
Table 2 The mean change scores on the Hand Eczema Severity Index (HECSI), according to changes measured with the anchor (Photoguide)
Photoguide HECSI
Perceived change n Mean change SDchange % change SD% change
4-step improvement 0 NA NA NA NA
3-step improvement 4 +715 429 +86% 12%
2-step improvement 18 +532 353 +69% 30%
1-step improvement (MIC) 65 +302 262 +59% 25%
No change 93 +12 206 5%a 56%a
1-step deterioration 32 233 196 83% 93%
2-step deterioration 3 683 552 326% 194%
3-step deterioration 0 NA NA NA NA
MIC, minimally important change; NA, not applicable. aOne extreme outlying case was excluded (300%).
Fig 1. Receiver operating characteristic (ROC) curve for various cutoff
points for change on the raw Hand Eczema Severity Index score.
© 2019 The Authors. British Journal of Dermatology
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between the patients falling within the proposed banding and
those falling outside it.12
Change scores
Smallest detectable change. The SDC of the HECSI was calculated
based on the analysis of 93 patients indicating no change on
the Photoguide between T0 and T1. Its value was 403 points.
Subsequently, the SDCs for the subgroups of severities were
determined: almost clear (n = 26), 132 points; moderate (n =
37), 329 points; severe (n = 26), 581 points; very severe (n
= 4), 672 points.
Minimally important change. The correlation between the change
in HECSI score and the change in the anchor (rho = 075) is
higher than the minimally recommended correlation of 03–05
for studying the MIC. Therefore, the Photoguide was considered
to be an appropriate anchor.18,19 Calculation of the MIC of
improvement according to our three used methods resulted in
the values shown in Table 3. The distribution of raw HECSI
change scores was visualized as the anchor-based distribution
for patients indicating that they had improved or indicating no
change, along with the three MIC values (Fig. 3).
Sensitivity analysis for low and high baseline
scores
The median value of the HECSI at baseline was 335 points.
Therefore, MIC values were separately calculated for patients
with a low baseline HECSI score (≤ 33 points) and patients
with a high baseline HECSI score (> 33 points). Details of the
MIC values are provided in Table 3 (and Tables S3 and S4 and
Figs S1 and S2; see Supporting Information).
Floor and ceiling effects
No floor or ceiling effects were seen: no patients achieved the
highest HECSI score of 360 and only three patients achieved
the lowest score of 0 at T1.
Discussion
In this study we found good responsiveness of the HECSI and
report values to aid interpretability of HECSI scores.
For interpretability of single scores, the anchor-based
approach gives an idea of what level of severity is represented
by a HECSI score. It is clear that the distribution of scores is
quite unequal: as severity rises, a gradually larger range of
HECSI points covers the severity categories. This corresponds
to what is found for the Eczema Area and Severity Index, a
very similar instrument used to measure severity in atopic der-
matitis.12
The anchor used in this study, the Photoguide, is a global
instrument that crudely measures hand eczema severity. The
high correlation between the Photoguide and the HECSI, along
with detailed knowledge of both instruments, gives sufficient
evidence that they measure many similar aspects of the
assessed construct: hand eczema severity. Therefore, the Pho-
toguide is a suitable anchor for the HECSI for single scores.
However, when longitudinal measurements are performed,
some aspects need consideration.
To determine the SDC, patients indicating no change were
identified using the ordinal Photoguide. However, patients can
change substantially on the HECSI while their baseline Photogu-
ide category does not change, particularly within the ‘severe’
and ‘very severe’ categories. This inflates the SDC because of the
large variance in HECSI scores that is found within the group of
patients indicating no change after 4–12 weeks (T1). In many
cases this results in an SDC larger than the MIC, which makes
the MIC meaningless because it then falls within the range of
values likely to be measurement error. Furthermore, the large
SDC is problematic because it means that there may be a small
but clinically meaningful change likely to be taking place, but
the HECSI is unable (according to the currently used anchor) to
detect this change beyond measurement error, and therefore it
cannot detect these small but clinically important changes.
Table 3 Minimally important change (MIC) for improvement on the








Points % Points % Points %
Mean cutoff 302 59 107 62 469 57
ROC curve 105 31 55 38 190 31
95% limit 351 87 163 95 501 71
MIC values are presented for the total HECSI, and for low (≤ 33)
and high (> 33) scores. MIC values for percentage decrease from
baseline (%) are presented. ROC, receiver operating characteristic.
Fig 2. Box plots of the distribution of the Hand Eczema Severity Index
(HECSI) by Photographic guide severity. Error bars are according to
Tukey. Not the whole range of the HECSI is shown (0–360).
© 2019 The Authors. British Journal of Dermatology
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For the change scores, a change of one step in severity on the
Photoguide as the cutoff for important change is an arbitrary
choice, which may be valid in hand eczema of lower severities.
However, when hand eczema is for example ‘very severe’, a
decrease in HECSI score that does not correspond to a one-step
decrease on the Photoguide may still count as a MIC for a
patient. This would make the MIC even smaller than the values
that we found. To determine this, we would have had to use a
different anchor, for example asking patients whether they
would rate their change as important. This would have been a
more patient-guided MIC, while we chose a clinician’s perspec-
tive on the MIC. From that perspective, the one-step improve-
ment on the Photoguide was the smallest possible change to
measure. In future studies, it would be interesting to see SDC
and MIC values obtained with a patient-guided anchor, possibly
also for higher and lower baseline severities separately.
Of the three MIC values obtained with the three methods,
the MIC obtained with the ROC curve may be the most valid.
The mean change score method does not actually represent a
minimally important difference, but more of a mean clear clinical
change, which inflates it compared with the cutoff point
between patients indicating no change and those indicating
that they had changed.20 The 95% limit method is based on
patients indicating no change, for whom the crude ordinal
categories of the Photoguide result in large SDs of the HECSI
score and an inflation of this method. Regardless, one should
Fig 3. Visual anchor-based distribution of raw
Hand Eczema Severity Index (HECSI) change
scores for patients with improved (green line)
and unchanged (blue dashed line) scores on
the anchor (Photoguide), along with the
minimally important change (MIC) values
obtained using three different methods. ROC,
receiver operating characteristic.
© 2019 The Authors. British Journal of Dermatology
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realize that all three mean MIC values fall within the limits of
agreement of the HECSI (at least when the Photoguide is used
as anchor), as currently represented by the SDC of 403
points. Therefore, we recommend to regard an improvement
of 41 points on the HECSI as the minimally measurable true
change.
The MIC and SDC values obtained in this study can help
interpret change scores on the HECSI and might facilitate
researchers in the calculation of sample sizes for clinical trials.
It is advised to use the MIC values expressing percentage
change for this, as MIC values are more stable this way, espe-
cially when there is much variability in baseline values.21
However, one should keep in mind that the MIC correspond-
ing to a one-step improvement on the Photoguide is probably
not always a sufficient clinical improvement when comparing
treatments.22 Various studies in hand eczema have defined ‘re-
sponse to treatment’ as an improvement of at least two steps
or achieving ‘clear’ or ‘almost clear’ on the used ordinal scale
(Photoguide, or other Physician’s Global Assessment).23,24 To
reach this Photoguide stage with the HECSI, an estimated
reduction of 54 points or 70% is needed, based on the results
of the current study (Table 2). Therefore, we suggest to use
≥ 75% improvement in HECSI score (HECSI 75) to define a
truly, clinically relevantly improved patient. This corresponds
to how the measurement of atopic dermatitis is currently
reported with ≥ 75% improvement in the Eczema Area and
Severity Index. Of note, although HECSI 75 can be reported to
aid interpretation, it should not necessarily be used for analy-
sis and trial design, as it turns the HECSI score into a binary
outcome, which is less efficient than using the HECSI in its
original continuous form.25 Reporting HECSI 50 is not useful,
as a 50% improvement is below all mean MIC values found in
the current study.
A strength of this study is that it was conducted according
to guidelines by COSMIN.5,9 Furthermore, we believe that the
results are generalizable to the white population of adult
patients with hand eczema (the used instruments are mainly
developed for use in white populations), as we included
patients from all severity groups. However, a degree of inter-
and intrarater variability exists,2 so the MIC values that we
report are in part dependent on how HECSI is scored in our
centre. To improve this, a detailed, consensus-based scoring
instruction for the HECSI should be made available in the
future.26 A limitation of the study is that the subgroup analy-
ses for low and high HECSI baseline values did not include
the minimum of 50 patients in each group of patients indicat-
ing that they had improved or indicating no change. This
could have influenced these results.
The values presented in this study provide a sense of how
HECSI scores can be interpreted. This should give researchers
a better understanding of the meaning of HECSI scores in
daily practice and stimulate its use in clinical trials. Further-
more, the study adds information on responsiveness as a mea-
surement property of the HECSI, establishing a firmer base on
which the HECSI may be adopted in a core outcome set for
hand eczema studies in the future.27
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